Approval · Notice of Compliance 21184 · 2018
RIXUBIS: Notice of Compliance 21184
Issued August 8, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21184
- Date
- August 8, 2018
- Company
- Shire Pharma Canada UlcToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug substance manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RIXUBIS | Not yet assigned | — |
Medicinal ingredients
- NONACOG GAMMA 500 UNIT per 5ML
- NONACOG GAMMA 1,000 UNIT per 5ML
- NONACOG GAMMA 2,000 UNIT per 5ML
- NONACOG GAMMA 250 UNIT per 5ML
- NONACOG GAMMA 3,000 UNIT per 5ML